Treatment of patients with specific subsets of carcinoma of an unknown primary site

Annals of Oncology

Volumn 17, Issue SUPPL. 10, 2006, Pages

  Fizazi, K ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKERATIN; ETOPOSIDE; LACTATE DEHYDROGENASE; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ADENOCARCINOMA; ARTICLE; AXILLARY LYMPH NODE; CANCER COMBINATION CHEMOTHERAPY; CARCINOMA; CARCINOMATOUS PERITONITIS; CERVICAL LYMPH NODE; CYSTADENOCARCINOMA; FUNCTIONAL ASSESSMENT; GENE EXPRESSION PROFILING; GERM CELL TUMOR; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; METASTASIS; MICROARRAY ANALYSIS; MULTIMODALITY CANCER THERAPY; NEUROENDOCRINE TUMOR; PAPILLARY CARCINOMA; PATIENT DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; RETROPERITONEAL CANCER; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; HUMANS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 33749609287     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl256     Document Type: Article

References (15)

1. Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
2. Bugat R, Bataillard A, Lesimple T et al. Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site. Br J Cancer 2003; 89 (Suppl 1): 59-66.
3. Briasoulis E, Tolis C, Bergh J, Pavlidis N. ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP). Ann Oncol 2005; 16 Suppl 1: 75-76.
4. Pavlidis N, Fizazi K. Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 2005; 54: 243-250.
5. Fizazi K, Schmoll HJ. Randomized trials in patients with Carcinoma of an Unknown Primary: The Past, the Present, and the Future. In Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
6. Lortholary A, El Kouri C, Ramée JF, Kerbrat P. Woman with an isolated adenocarcinoma in the axillary lymph node of an unknown primary site. Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
7. Vlastos G, Jean ME, Mirza AN et al. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 2001; 8: 425-431.
8. Hainsworth JD. Treatment of patients with favorable subsets of unknown primary cancer. In Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
9. Kaminsky MC, Blot E. Squamous cell carcinoma of a unknown primary tumor located in the cervical lymph nodes. In Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
10. Currow DC, Findlay M, Cox K, Harnett PR. Elevated germ cell markers in carcinoma of uncertain primary site do not predict response to platinum based chemotherapy. Eur J Cancer 1996; 32A: 2357-2359.
11. Lenzi R, Hess KR, Abbruzzese MC et al. Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: Favorable subsets of patients with unknown primary carcinoma? J Clin Oncol 1997; 15: 2056-2062.
12. Saghatchian M, Fizazi K, Borel C et al. Carcinoma of an unknown primary site: A chemotherapy strategy based on histological differentiation - results of a prospective study. Ann Oncol 2001; 12: 535-540.
13. Lesimple T, Balaña C. Carcinoma at unknown primary in a single site. In Fizazi K (ed.). Carcinoma of an Unknown Primary Site. 1st edn. New York, PA: Taylor & Francis Books LLC, 2006.
14. Culine S, Kramar A, Saghatchian M et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002; 20: 4679-4683.
15. van de Wouw AJ, Jansen RL, Griffioen AW, Hillen HF. Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. Anticancer Res 2004; 24: 297-301.